Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VivaSens is a desensitizing varnish developed and manufactured by Ivoclar Vivadent for the treatment of dentin hypersensitivity. It is a topical dental product formulated as a clear lacquer based on ethanol, water, and hydroxypropyl cellulose, containing active ingredients such as potassium fluoride, polyethylene glycol dimethacrylate, and other methacrylates. VivaSens employs a synergistic mechanism of action: it forms a protective lacquer coating on the root surface to shield exposed tooth necks from external stimuli, while simultaneously blocking dentinal tubules through the precipitation of calcium ions and proteins within the dentinal fluid. The inclusion of potassium fluoride provides additional desensitizing benefits by potentially affecting nerve transmission. It is typically used in clinical settings to manage natural dental hypersensitivity and was recently evaluated in a 2024 randomized controlled clinical trial led by researcher Nourah Mulfi Aljasser.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on VivaSens.